News | News By Subject | News by Disease News By Date | Search News

Liver cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Onxeo (ONXEO.PA) Plunges After Liver Cancer Drug Fails Late-Stage Study     9/12/2017
7 PDUFA Dates to Mark on Your Calendars for September     9/7/2017
Backed By Two Drug Powerhouses, GenSight Alum Launches New Biotech With $40 Million     5/4/2017
Bristol-Myers Squibb (BMY) Slams Down $100 Million to Make a Play Into NASH     11/14/2016
Galectin (GALT) Stock Craters After Phase IIa NASH Failure     9/28/2016
Bayer (BAY)'s Regorafenib Extends Lives of Liver Cancer Patients in Late Stage Study     5/5/2016
The Three Most Important Drugs in Gilead (GILD)'s Pipeline     12/8/2015
Raptor (RPTP)'s Phase IIb CyNCh Study Fails To Meet Primary Endpoint, Shares Skid     9/15/2015
AbbVie (ABBV)’s Viekira Pak Clears Another Hurdle, 100% HCV-1b Clearance Rate in Phase III Trial     6/25/2015
La Jolla Pharma (LJPC) Bails On Two Drug Programs, Shifts Focus to Rare Disease     5/11/2015
Conatus Pharma Shares Soar On Successful Emricasan Phase II Results     3/27/2015
Nektar Therapeutics (NKTR) Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry     3/20/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014

News from Around the Web
Excess Weight Linked To 8 More Cancers, Washington University School of Medicine Reveals     8/31/2016
Broccoli May Protect Against Liver Cancer, University of Illinois Study Shows     3/4/2016
Nanoparticle Therapy That Uses LDL And Fish Oil Kills Liver Cancer Cells, UT Southwestern Medical Center Study     2/9/2016
Studying Cancer DNA In Blood May Help Personalize Treatment In Liver Cancer, Hiroshima University Reveals     11/3/2015
Prolonged TV Watching Linked To Eight Leading Causes Of Death, American Journal of Preventive Medicine Publishes     10/28/2015
Could Image Mapping Offer Way To Do Noninvasive Liver Biopsies?     10/20/2015
New DNA Testing For Liver Cancer Could Improve Survival, Hiroshima University Study     9/11/2015
Citrus Scent Could Help Fight Liver Cancer, Ruhr-University Study     1/21/2015
Herbal Medicines Could Contain Dangerous Levels Of Toxic Mold, University Of Peshawar     10/27/2014
A Genetic Catch-22 Promotes and Prevents Liver Cancer, University of Southern California Study     8/7/2013
Breakthrough Chemo Bath Treats Liver Cancer for First Time in UK, Southampton General Hospital Reveals     11/12/2012
Metabolic Syndrome Increases Risk of Both Major Types of Primary Liver Cancer, National Cancer Institute Study     7/28/2011
Experts at University of Hong Kong Find Rogue Stem Cells in Liver Cancer     7/7/2011
Six-Year Study Confirms Australia's Sirtex Medical's Liver Cancer Therapy is Safe and Effective     7/7/2011
Discovery in Liver Cancer Cells Provides New Target for Drugs, Virginia Commonwealth University Study     3/23/2011

Press Releases
TRACON Pharma (TCON) Announces Positive Results From NCI Phase I/II Trial Of TRC105 And Nexavar In Hepatocellular Cancer Published In Clinical Cancer Research     8/16/2017
Can-Fite BioPharma (CFBI) Completes Patient Enrolment For Its Phase II Study Of Namodenoson In The Treatment Of Liver Cancer     8/9/2017
Data Monitoring Committee Completes Mid-Study Review Of Celsion (CLSN)’s Phase III ThermoDox OPTIMA Study In Primary Liver Cancer     8/7/2017
TRANSGENE (ENX:TNG) Release: First Patient Dosed In A Phase 1/2 Trial Of Pexa-Vec + Opdivo For The First-Line Treatment Of Advanced Liver Cancer     7/31/2017
Midatech: Completion Of Pre-Clinical Liver Cancer Programme     7/26/2017
SillaJen And Lee's Pharmaceutical Announce Approval By The China CFDA To Commence Phase III Clinical Trial For Oncolytic Immunotherapy, Pexa-Vec, In Liver Cancer     7/21/2017
Tiziana Life Sciences Plc Announces Initiation Of A Phase IIa Clinical Trial With Milciclib In Patients With Hepatocellular Carcinoma     7/19/2017
Eureka Therapeutics And City of Hope Announce Agreement To Conduct Phase I Clinical Trial Of Investigational Et1402l1 Car-T Therapy In Liver Cancer     6/7/2017
Sirtex Medical (SRX.AX) Release: SIR-Spheres Y-90 Resin Microspheres Showed No Significant Difference In Overall Survival (OS) Compared To Sorafenib In Advanced HCC With Significantly Fewer Severe Adverse Events, New Asia-Pacific Study Finds     6/6/2017
Vital Therapies (VTL) Announces Characteristics Of Early Subjects In VTL-308 Pivotal Study Of ELAD System In Severe Alcoholic Hepatitis     6/5/2017
US Medical Innovations Announces Canady Helios Cold Plasma And Hybrid Plasma Scalpels Used In The First Clinical Liver Resection Performed To Remove And Selectively Kill Liver Cancer Tumor Cells     6/5/2017
Onxeo Announces 10th Positive DSMB Recommendation To Continue Livatag Relive Phase III Trial In HCC     5/23/2017
ASCO Publishes Abstract Of SIRveNIB, An Investigator-Led Asia Pacific Primary Liver Cancer Study To Be Presented At ASCO Annual Meeting In Chicago, 4 June 2017     5/18/2017
Adaptimmune (ADAP) Announces Initiation Of Study To Evaluate SPEAR T-Cell Therapy Targeting AFP In Liver Cancer     5/10/2017
Onxeo Announces Allowance Of U.S. Patent For Livatag In Hepatocellular Carcinoma     5/10/2017